Citations (61)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Karl Rickels & Hans Juergen Moeller. (2019) Benzodiazepines in anxiety disorders: Reassessment of usefulness and safety. The World Journal of Biological Psychiatry 20:7, pages 514-518.
Read now
Read now
Farid Talih, Jean Ajaltouni, Hiba Ghandour, Ahmad Subhi Abu-Mohammad & Firas Kobeissy. (2018) Insomnia in hospitalized psychiatric patients: prevalence and associated factors. Neuropsychiatric Disease and Treatment 14, pages 969-975.
Read now
Read now
Borwin Bandelow, Sophie Michaelis & Dirk Wedekind. (2017) Treatment of anxiety disorders. Dialogues in Clinical Neuroscience 19:2, pages 93-107.
Read now
Read now
Bernardo Dell’Osso, Umberto Albert, Anna Rita Atti, Claudia Carmassi, Giuseppe Carrà, Fiammetta Cosci, Valeria Del Vecchio, Marco Di Nicola, Silvia Ferrari, Arianna Goracci, Felice Iasevoli, Mario Luciano, Giovanni Martinotti, Maria Giulia Nanni, Alessandra Nivoli, Federica Pinna, Nicola Poloni, Maurizio Pompili, Gaia Sampogna, Ilaria Tarricone, Sarah Tosato, Umberto Volpe & Andrea Fiorillo. (2015) Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice. Neuropsychiatric Disease and Treatment 11, pages 1885-1909.
Read now
Read now
Jennifer A Reinhold & Karl Rickels. (2015) Pharmacological treatment for generalized anxiety disorder in adults: an update. Expert Opinion on Pharmacotherapy 16:11, pages 1669-1681.
Read now
Read now
Articles from other publishers (56)
Denong Liu, Qingyu Zhang, Zhijia Zhao, Mengjia Chen, Yanbin Hou, Guanjun Wang, Haowei Shen, Huaqiang Zhu, Yunxin Ji, Liemin Ruan & Zhongze Lou. (2023) Benzodiazepine-Receptor Agonist Utilization in Outpatients with Anxiety Disorder: A Retrospective Study Based on Electronic Healthcare Data from a Large General Tertiary Hospital. Healthcare 11:4, pages 554.
Crossref
Crossref
Virginia Silveira, Karina Taciana Santos Rubio & Maria Elvira Poleti Martucci. (2022) Anxiolytic effect of Anthemis nobilis L. (roman chamomile) and Citrus reticulata Blanco (tangerine) essential oils using the light-dark test in zebrafish (Danio rerio). Journal of Ethnopharmacology 298, pages 115580.
Crossref
Crossref
Carlos Aparecido da Silva Junior, Luís Gustavo A. Patrone, Vivian Biancardi, Heloísa H. Vilela-Costa, Danuzia A. Marques, Caroline Cristina-Silva, Kaoma Stephani da Costa Silva, Kênia C. Bícego, Raphael E. Szawka & Luciane H. Gargaglioni. (2022) Sexually dimorphic effects of prenatal diazepam exposure on respiratory control and the monoaminergic system of neonate and young rats. Pflügers Archiv - European Journal of Physiology 474:11, pages 1185-1200.
Crossref
Crossref
De Wet Wolmarans, Michelle Prinsloo, Soraya Seedat, Dan J. Stein, Brian H. Harvey & Geoffrey de Brouwer. (2022) Escitalopram and lorazepam differentially affect nesting and open field behaviour in deer mice exposed to an anxiogenic environment. Neuroscience Research 177, pages 85-93.
Crossref
Crossref
Vladan Starcevic. (2022) Representation of Benzodiazepines in Treatment Guidelines: The Paradox of Undesirable Objectivity. Psychotherapy and Psychosomatics 91:5, pages 295-299.
Crossref
Crossref
Stéphanie Baggio, Vladan Starcevic, Patrick Heller, Karen Brändle, Irina Franke, Andreas Schneeberger, Anna Buadze, Alex Gamma, Roman Schleifer, Laurent Gétaz, Hans Wolff & Michael Liebrenz. (2021) Relationship between benzodiazepine prescription, aggressive behavior, and behavioral disinhibition: a retrospective study in a Swiss prison. Harm Reduction Journal 18:1.
Crossref
Crossref
Hye‐Min Sohn, Hyo‐Seok Na, Dongsik Lim, In Koung Yi, Sun‐Woo Nam, Sang‐Hwan Do & Jung‐Won Hwang. (2021) Immediate retrograde amnesia induced by midazolam: A prospective, non‐randomised cohort study. International Journal of Clinical Practice 75:11.
Crossref
Crossref
Mathilde Bonnay, Thomas Soeiro, Rachel Megard, Joelle Micallef, Benjamin Rolland & Mathieu Chappuy. (2021) Usages et bon usage des benzodiazépines anxiolytiques et hypnotiques. Annales Médico-psychologiques, revue psychiatrique 179:8, pages 748-756.
Crossref
Crossref
Yang Du, Biao Du, Yun Diao, Zubin Yin, Jin Li, Yunfeng Shu, Zizhen Zhang & Lizhi Chen. (2021) Comparative efficacy and acceptability of antidepressants and benzodiazepines for the treatment of panic disorder: A systematic review and network meta-analysis. Asian Journal of Psychiatry 60, pages 102664.
Crossref
Crossref
Nancy A. Pachana & Gerard J. Byrne. 2021. Anxiety in Older People. Anxiety in Older People
226
240
.
Madhusoothanan Bhagavathi Perumal & Pankaj Sah. 2021. Anxiety in Older People. Anxiety in Older People
205
225
.
Monika Maciąg, Agnieszka Michalak, Krystyna Skalicka-Woźniak, Maria Zykubek, Andrzej Ciszewski & Barbara Budzyńska. (2020) Zebrafish and mouse models for anxiety evaluation – A comparative study with xanthotoxin as a model compound. Brain Research Bulletin 165, pages 139-145.
Crossref
Crossref
Marina S. Melani, Jéssica M. Paiva, Maria C. Silva, Mauro V. Mendlowicz, Ivan Figueira, Carla Marques‐Portella, Mariana P. Luz, Paula Rui Ventura & William Berger. (2020) Absence of definitive scientific evidence that benzodiazepines could hinder the efficacy of exposure‐based interventions in adults with anxiety or posttraumatic stress disorders: A systematic review of randomized clinical trials. Depression and Anxiety 37:12, pages 1231-1242.
Crossref
Crossref
Heidi Taipale, Hanna Särkilä, Antti Tanskanen, Terhi Kurko, Tero Taiminen, Jari Tiihonen, Reijo Sund, Annamari Tuulio-Henriksson, Leena Saastamoinen & Jarmo Hietala. (2020) Incidence of and Characteristics Associated With Long-term Benzodiazepine Use in Finland. JAMA Network Open 3:10, pages e2019029.
Crossref
Crossref
Yu-Ting Chen, Chia-Yih Liu, Chia-Ming Chang, Yu-Ming Lai, Bi-Hwa Wang, Tsui-Yun Yang & Shih-Chieh Hsu. (2020) Perceptions, clinical characteristics, and other factors associated with prolonged and high daily dose of benzodiazepine use among patients with anxiety or depressive disorders. Journal of Affective Disorders 271, pages 215-223.
Crossref
Crossref
Adam M. Perkins, Julia Große Bley, Anthony J. Cleare, Allan H. Young, Philip J. Corr, Ralf Dohrenbusch & Ulrich Ettinger. (2020) Threat-sensitivity in affective disorders: A case-control study. Journal of Affective Disorders 266, pages 595-602.
Crossref
Crossref
I. N. Semenenya. (2020) Psychosomatic disorders: causes, development mechanisms, clinical manifestations and feasibilities of autopsychocorrection. Proceedings of the National Academy of Sciences of Belarus, Medical series 17:1, pages 101-121.
Crossref
Crossref
Fiammetta Cosci & Guy Chouinard. (2020) Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications. Psychotherapy and Psychosomatics 89:5, pages 283-306.
Crossref
Crossref
Anne Richards, Jennifer C. Kanady & Thomas C. Neylan. (2019) Sleep disturbance in PTSD and other anxiety-related disorders: an updated review of clinical features, physiological characteristics, and psychological and neurobiological mechanisms. Neuropsychopharmacology 45:1, pages 55-73.
Crossref
Crossref
Richard Balon & Vladan Starcevic. 2020. Anxiety Disorders. Anxiety Disorders
367
388
.
Borwin Bandelow. 2020. Anxiety Disorders. Anxiety Disorders
347
365
.
Arne Einar Vaaler. 2020. Management of Severe Traumatic Brain Injury. Management of Severe Traumatic Brain Injury
537
543
.
Laiana A Quagliato, Fiammetta Cosci, Richard I Shader, Edward K Silberman, Vladan Starcevic, Richard Balon, Steven L Dubovsky, Carl Salzman, John H Krystal, Steve J Weintraub, Rafael C Freire & Antonio E Nardi. (2019) Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatment. Journal of Psychopharmacology 33:11, pages 1340-1351.
Crossref
Crossref
Lorenzo Sansalone, Joshua Bratsch-Prince, Sicheng TangBurjor CaptainDavid D. Mott & Françisco M. Raymo. (2019)
Photopotentiation of the GABA
A
receptor with caged diazepam
. Proceedings of the National Academy of Sciences 116:42, pages 21176-21184.
Crossref
Crossref
Vera De Carlo, Benedetta Grancini, Matteo Vismara, Beatrice Benatti, Chiara Arici, Laura Cremaschi, Giovanna Cirnigliaro, Luca Degoni, Lucio Oldani, Carlotta Palazzo, Ira D. Glick, Caterina Viganò & Bernardo Dell'Osso. (2019) Exploring characteristics associated with first benzodiazepine prescription in patients with affective disorders and related diagnoses. Human Psychopharmacology: Clinical and Experimental 34:3, pages e2695.
Crossref
Crossref
Clarice S. Madruga, Thales L. Paim, Hamer N. Palhares, Andre C. Miguel, Luciana T.S. Massaro, Raul Caetano & Ronaldo R. Laranjeira. (2019) Prevalence of and pathways to benzodiazepine use in Brazil: the role of depression, sleep, and sedentary lifestyle. Brazilian Journal of Psychiatry 41:1, pages 44-50.
Crossref
Crossref
Laura Cremaschi, Benedetta Grancini, Vera De Carlo, Sara Pozzoli, A. Carlo Altamura & Bernardo Dell’Osso. (2018) Benzodiazepine ingestion as a way to die by suicide and related safety: the case of an elderly patient. Aging Clinical and Experimental Research 31:2, pages 287-289.
Crossref
Crossref
Cristina Luz Tosta, Gabriela Pandini Silote, Maria Paula Fracalossi, Ariandra Guerini Sartim, Roberto Andreatini, Sâmia Regiane Lourenço Joca & Vanessa Beijamini. (2019) S-ketamine reduces marble burying behaviour: Involvement of ventromedial orbitofrontal cortex and AMPA receptors. Neuropharmacology 144, pages 233-243.
Crossref
Crossref
Muhammad Torequl Islam, Eunüs S. Ali, Shaikh J. Uddin, Subrata Shaw, Md Amirul Islam, Md Iqbal Ahmed, Manik Chandra Shill, Utpal Kumar Karmakar, Nagendra Sastry Yarla, Ishaq N. Khan, Md Morsaline Billah, Magdalena D. Pieczynska, Gokhan Zengin, Clemens Malainer, Ferdinando Nicoletti, Diana Gulei, Ioana Berindan-Neagoe, Apostol Apostolov, Maciej Banach, Andy W.K. Yeung, Amr El-Demerdash, Jianbo Xiao, Prasanta Dey, Santosh Yele, Artur Jóźwik, Nina Strzałkowska, Joanna Marchewka, Kannan R.R. Rengasamy, Jarosław Horbańczuk, Mohammad Amjad Kamal, Mohammad S. Mubarak, Siddhartha K. Mishra, Jamil A. Shilpi & Atanas G. Atanasov. (2018) Phytol: A review of biomedical activities. Food and Chemical Toxicology 121, pages 82-94.
Crossref
Crossref
Benedetta Grancini, Vera De Carlo, Mariacarlotta Palazzo, Matteo Vismara, Chiara Arici, Laura Cremaschi, Beatrice Benatti, A. Carlo Altamura & Bernardo Dell’Osso. (2018) Does initial use of benzodiazepines delay an adequate pharmacological treatment? A multicentre analysis in patients with psychotic and affective disorders. International Clinical Psychopharmacology 33:3, pages 140-146.
Crossref
Crossref
Luana D. Laurito, Carla P. Loureiro, Rafaela V. Dias, Paula Vigne, Gabriela B. de Menezes, Rafael C. Freire, Ulrich Stangier & Leonardo F. Fontenelle. (2018) Predictors of benzodiazepine use in a transdiagnostic sample of panic disorder, social anxiety disorder, and obsessive-compulsive disorder patients. Psychiatry Research 262, pages 237-245.
Crossref
Crossref
. 2018. The Immune System and Mental Health. The Immune System and Mental Health
555
664
.
Milan Latas, Goran Trajković, Dimitar Bonevski, Andromahi Naumovska, Dušanka Vučinić Latas, Zoran Bukumirić & Vladan Starčević. (2018) Psychiatrists' treatment preferences for generalized anxiety disorder. Human Psychopharmacology: Clinical and Experimental 33:1, pages e2643.
Crossref
Crossref
Mª José Díaz-Gutiérrez, Mónica Martínez-Cengotitabengoa, Estíbaliz Sáez de Adana, Ana Isabel Cano, Maria Teresa Martínez-Cengotitabengoa, Ariadna Besga, Rafael Segarra & Ana González-Pinto. (2017) Relationship between the use of benzodiazepines and falls in older adults: A systematic review. Maturitas 101, pages 17-22.
Crossref
Crossref
Simon M. Holliday, Simon Morgan, Amanda Tapley, Kim M. Henderson, Adrian J. Dunlop, Mieke L. van Driel, Neil A. Spike, Lawrence A. McArthur, Jean Ball, Christopher J. Oldmeadow & Parker J. Magin. (2017) The pattern of anxiolytic and hypnotic management by Australian general practice trainees. Drug and Alcohol Review 36:2, pages 261-269.
Crossref
Crossref
Bettina Moritz, Marcelo Liborio Schwarzbold, Ricardo Guarnieri, Alexandre Paim Diaz, Ana Lúcia S. Rodrigues & Alcir Luiz Dafre. (2017) Effects of ascorbic acid on anxiety state and affect in a non-clinical sample. Acta Neurobiologiae Experimentalis 77:4, pages 362-372.
Crossref
Crossref
华军 何. (2017) The Development of Therapeutic Drugs for Insomnia. Hans Journal of Medicinal Chemistry 05:01, pages 1-10.
Crossref
Crossref
Michael Liebrenz, Marcel Schneider, Anna Buadze, Marie-Therese Gehring, Anish Dube & Carlo Caflisch. (2016) Attitudes towards a maintenance (-agonist) treatment approach in high-dose benzodiazepine-dependent patients: a qualitative study. Harm Reduction Journal 13:1.
Crossref
Crossref
Vladan Starcevic. (2016) The importance of distinguishing between dependence and addiction in the context of long-term benzodiazepine use. Australian & New Zealand Journal of Psychiatry 50:11, pages 1111-1112.
Crossref
Crossref
Beatrice Benatti, Giulia Camuri, Bernardo Dell’Osso, Laura Cremaschi, Ester Sembira, Carlotta Palazzo, Lucio Oldani, Cristina Dobrea, Chiara Arici, Diego Primavera, Bernardo Carpiniello, Filippo Castellano, Giuseppe Carrà, Massimo Clerici, David S. Baldwin & Alfredo Carlo Altamura. (2016) Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?. International Clinical Psychopharmacology 31:6, pages 347-352.
Crossref
Crossref
David Franklin Niedrig, Liesa Hoppe, Sarah Mächler, Heike Russmann & Stefan Russmann. (2016) Benzodiazepine Use During Hospitalization: Automated Identification of Potential Medication Errors and Systematic Assessment of Preventable Adverse Events. PLOS ONE 11:10, pages e0163224.
Crossref
Crossref
Irene Bighelli, Carlotta Trespidi, Mariasole Castellazzi, Andrea Cipriani, Toshi A Furukawa, Francesca Girlanda, Giuseppe Guaiana, Markus Koesters & Corrado Barbui. (2016) Antidepressants and benzodiazepines for panic disorder in adults. Cochrane Database of Systematic Reviews 2016:9.
Crossref
Crossref
Vladan Starcevic, David Berle, Maria Conceição do Rosário, Vlasios Brakoulias, Ygor A. Ferrão, Kirupamani Viswasam, Roseli Shavitt, Euripedes Miguel & Leonardo F. Fontenelle. (2016) Use of benzodiazepines in obsessive–compulsive disorder. International Clinical Psychopharmacology 31:1, pages 27-33.
Crossref
Crossref
V. Starcevic & D.J. Castle. 2016. Stress: Concepts, Cognition, Emotion, and Behavior. Stress: Concepts, Cognition, Emotion, and Behavior
203
211
.
M. Mofizul Islam, Suzanne Nielsen, Ian S. McRae, Paul S. Haber, Apo Demirkol, Bridin Murnion, Hester Wilson & Katherine M. Conigrave. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
283
292
.
Fiammetta Cosci. 2016. Panic Disorder. Panic Disorder
113
125
.
Esa R. Korpi, Bjørnar den Hollander, Usman Farooq, Elena Vashchinkina, Ramamoorthy Rajkumar, David J. Nutt, Petri Hyytiä & Gavin S. Dawe. (2015) Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse. Pharmacological Reviews 67:4, pages 872-1004.
Crossref
Crossref
David W. Galarneau & Erich J. Conrad. (2015) Benzodiazepine Intoxication and Withdrawal. Hospital Medicine Clinics 4:4, pages 513-525.
Crossref
Crossref
Татјана Петрушевска. (2015) Употреба на бензодијазепини кај пациенти на метадонски третман. Macedonian Medical Electronic Journal 1:1, pages 1-262.
Crossref
Crossref
Ran Lin, Danielle Rittenhouse, Katelyn Sweeney, Prasanth Potluri & Douglas C. Wallace. (2015) TSPO, a Mitochondrial Outer Membrane Protein, Controls Ethanol-Related Behaviors in Drosophila. PLOS Genetics 11:8, pages e1005366.
Crossref
Crossref
Sean D Hood. (2015) Latest guidelines for the management of the anxiety disorders – a report from The International Anxiety Disorders Society Conference, Melbourne 2014. Australasian Psychiatry 23:4, pages 388-391.
Crossref
Crossref
Vladan Starcevic. (2015) Generalized anxiety disorder: psychopharmacotherapy update on a common and commonly overlooked condition. Australasian Psychiatry 23:4, pages 338-342.
Crossref
Crossref
Richard Balon, Giovanni A. Fava & Karl Rickels. (2015) Need for a realistic appraisal of benzodiazepines. World Psychiatry 14:2, pages 243-244.
Crossref
Crossref
Jaymes V. Fairfax-Columbo & David DeMatteo. (2015) Are Bioequivalents Really Equal?: Generic Substitution in the Context of
Mental Illness. Indiana Health Law Review 12:1, pages 281-326.
Crossref
Crossref
Vladan Starcevic, Vlasios Brakoulias, Kirupamani Viswasam & David Berle. (2015) Inconsistent Portrayal of Medication Dependence, Withdrawal and Discontinuation Symptoms in Treatment Guidelines for Anxiety Disorders. Psychotherapy and Psychosomatics 84:6, pages 379-380.
Crossref
Crossref
Virginia Silveira, Karina Taciana Santos Rubio & Maria Elvira Poleti Martucci. (2022) Anxiolytic Effect of Anthemis Nobilis L. (Roman Chamomile) and Citrus Reticulata Blanco (Tangerine) Essential Oils Using the Light-Dark Test in Zebrafish (Danio Rerio). SSRN Electronic Journal.
Crossref
Crossref